Record sales month in New Zealand and Australia
Kia ora koutou nga kaipupuri hea o Rua,
Tena tatou i tenei wa o te koanga, kei te tangi te Pipiwharauroa, e tohu ana ki a tatou kua tae mai te wa mo te whakato i nga tipu.
I tenei wa, kei te kite matou i nga hua o nga mahi nui kua mahia, kei te eke tonu ki nga taumata i wawatatia, heoi he mahi nui tonu kei mua i a matou.
Spring greetings. The Pīpīwharauroa calls out, heralding the time for planting. As the season shifts, we begin to see the first fruits of our labour. The path toward the dreams we once envisioned is unfolding before us, yet much work still lies ahead.
September was a milestone month for Rua Bioscience, delivering record sales across both our New Zealand and Australian markets. This achievement reflects the continued momentum behind Rua’s growth strategy — working closely with trusted cultivators to deliver high-quality products consistently to prescribers and pharmacies in key markets.
Australia
In Australia, our record sales demonstrate growing demand and confidence in Rua’s product portfolio.
This performance is particularly encouraging given the highly competitive nature of the market and underscores the strength of the sales and distribution partnerships we have built over the past 18 months. It’s a key market in our International expansion strategy and these relationships are now translating into tangible results. This is providing a solid foundation for sustained growth.
Aotearoa New Zealand
In New Zealand, Rua continues to strengthen its position as the market evolves. The expansion of our high quality product range has been well received by prescribers and patients alike, driving record domestic sales in September. Our teams efforts to deepen engagement with clinics and pharmacies nationwide are resulting in consistent volume growth and enhanced presence across NZ.
The overall medicinal cannabis market in New Zealand is experiencing steady growth. Data to June 2025 highlights shows a steady increase in the number of medicinal cannabis products prescribed as more Doctors become comfortable integrating these therapies into patient care
Czech Republic - New market entry
September marked another milestone with the official entry into the Czech Republic, a growing European medicinal cannabis market. In partnership with our distributor, Motagon, we have launched our first Rua product. Initial prescriptions are already being filled, and this marks the beginning of a new revenue stream and a foothold in Central Europe.
The Czech Republic is part of our longer-term strategy to establish Rua Bioscience in well-regulated, growth-ready markets. By working closely with trusted, in-market partners, we’re setting up a scalable pipeline for future products, while maintaining a lean cost structure.
Germany – Sales recovering after supply gap
After a brief period of being out of stock, sales in Germany have resumed and are steadily growing. Prescriber demand remains strong, and we’re working closely with our distribution partners to ensure more consistent supply moving forward. Germany remains one of our most promising markets in terms of scale and reimbursement access, and we’re focused on building reliability and trust as our presence grows.
United Kingdom – Early-stage momentum
The UK market remains in its early stages for Rua, with brand presence and prescriber relationships still developing. Revenue is small but growing, and we continue to see value in building a foundation in this market, particularly as regulatory and clinical pathways mature.
Looking ahead
Our significant progress across New Zealand, Australia, and now launching in the Czech Republic reflects the strength of Rua’s focused, capital-conscious approach. With revenue pipelines now in five markets we are building momentum and resilience in our business model. And most importantly, supporting more patients with high-quality, consistent medicinal cannabis products.
As always, thank you for your ongoing support as we continue to grow Rua Bioscience into a globally connected, proudly Te Tairawhiti-founded medicinal cannabis company.
Pera i te Pipiwharauroa e rere tawhiti mai ana i Ahitereiria ki Aotearoa, kei te mohio matou, kaore ia e haere ngatahi mai, he tira tana hei tautoko i tana haere.
Ko koutou ena, nga kaitautoko o Rua e awhi tonu mai ana i te kaupapa i toko ake i te timatanga o tenei haerenga nui.
Just like the Pīpīwharauroa, which journeys from Australia to Aotearoa, we know it doesn’t travel alone - it flies with the support of others. In the same way, we acknowledge you, our supporters, who have stood by our kaupapa since the very beginning of this long journey.
Ngā mihi nui